The contraceptives market based on hormones or spermicides in Switzerland has been in a consistent decline from 2013 to 2023, where the value stood at approximately $62.127 million USD. From 2024 onwards, the trend remains negative with the market size forecasted to reach $44.354 million USD by 2028. Over the last two years, the year-on-year variation has been around -5.57%. The compounded annual growth rate (CAGR) over the past five years up to 2023 is approximately -3.62%, and the projected five-year CAGR from 2024 to 2028 is about -5.39%.
Trends to watch for include shifts towards non-hormonal and natural contraceptive methods, increased consumer awareness about potential side effects of hormonal contraceptives, and advancing technologies in contraception. The introduction and acceptance of new, innovative contraceptive solutions might alter the current market trajectories significantly.
